Careers  |  Sign In  |  Register

Latest in Rheumatology

Reuters Health • The Doctor's Channel Daily Newscast

Birth defects uncommon after exposure to leflunomide

NEW YORK (Reuters Health) – Birth defects are uncommon in offspring of women exposed to leflunomide before conception or in the first trimester of pregnancy, according to a report in the February 3rd online Arthritis & Rheumatism. “From the available data, we have not yet demonstrated that...

Reuters Health • The Doctor's Channel Daily Newscast

Severe cryoglobulinemic vasculitis responds to rituximab therapy

NEW YORK (Reuters Health) – Rituximab monotherapy is “a very good option” for severe cryoglobulinemic vasculitis (CV), according to the authors of an Italian study published online December 6 in Arthritis & Rheumatism. “RTX (rituximab) is superior, also in the long term, to standard...

Reuters Health • The Doctor's Channel Daily Newscast

Rituximab may be effective for systemic rheumatoid vasculitis

NEW YORK (Reuters Health) – Patients with systemic vasculitis associated with rheumatoid arthritis respond well to rituximab therapy, French investigators report in Arthritis Care & Research online November 10. “Complete remission of SRV was achieved in nearly three quarters of patients receiving...